E. D. de Kock

Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults

M. Demoitié, W. Ballou, Joe D. Cohen, 2010, Clinical and Vaccine Immunology.

The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans

Joe D. Cohen, O. Ofori-Anyinam, P. Moris, 2009, Human vaccines.

Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in Gauteng Province, South Africa.

O. Perovic, D. Lewis, E. D. de Kock, 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies

S. Birring, N. Garton, M. Barer, 2020, The Lancet. Infectious diseases.

Twenty-four hour face mask sampling in pulmonary tuberculosis reveals three distinct patterns of bacterial aerosol production dissociated from conventional markers of transmission risk

M. Barer, S. Birring, A. Stoltz, 2018 .